nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.331	0.428	CbGbCtD
Omeprazole—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.305	0.395	CbGbCtD
Omeprazole—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.136	0.177	CbGbCtD
Omeprazole—Oesophageal stenosis—Riluzole—amyotrophic lateral sclerosis	0.0121	0.061	CcSEcCtD
Omeprazole—Lansoprazole—MAPT—amyotrophic lateral sclerosis	0.00578	1	CrCbGaD
Omeprazole—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.0244	CcSEcCtD
Omeprazole—Hernia—Riluzole—amyotrophic lateral sclerosis	0.004	0.0201	CcSEcCtD
Omeprazole—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0195	CcSEcCtD
Omeprazole—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0173	CcSEcCtD
Omeprazole—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0171	CcSEcCtD
Omeprazole—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0161	CcSEcCtD
Omeprazole—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0159	CcSEcCtD
Omeprazole—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0157	CcSEcCtD
Omeprazole—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00309	0.0155	CcSEcCtD
Omeprazole—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0141	CcSEcCtD
Omeprazole—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0132	CcSEcCtD
Omeprazole—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0131	CcSEcCtD
Omeprazole—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0117	CcSEcCtD
Omeprazole—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0117	CcSEcCtD
Omeprazole—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0115	CcSEcCtD
Omeprazole—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0107	CcSEcCtD
Omeprazole—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0105	CcSEcCtD
Omeprazole—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0104	CcSEcCtD
Omeprazole—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0102	CcSEcCtD
Omeprazole—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.002	0.01	CcSEcCtD
Omeprazole—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00944	CcSEcCtD
Omeprazole—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00944	CcSEcCtD
Omeprazole—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00944	CcSEcCtD
Omeprazole—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00939	CcSEcCtD
Omeprazole—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00922	CcSEcCtD
Omeprazole—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00902	CcSEcCtD
Omeprazole—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00897	CcSEcCtD
Omeprazole—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00854	CcSEcCtD
Omeprazole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00828	CcSEcCtD
Omeprazole—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00803	CcSEcCtD
Omeprazole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00803	CcSEcCtD
Omeprazole—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00788	CcSEcCtD
Omeprazole—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00784	CcSEcCtD
Omeprazole—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00781	CcSEcCtD
Omeprazole—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00766	CcSEcCtD
Omeprazole—Injury—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00746	CcSEcCtD
Omeprazole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0073	CcSEcCtD
Omeprazole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0072	CcSEcCtD
Omeprazole—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00711	CcSEcCtD
Omeprazole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00705	CcSEcCtD
Omeprazole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00688	CcSEcCtD
Omeprazole—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00685	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00685	CcSEcCtD
Omeprazole—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00685	CcSEcCtD
Omeprazole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00675	CcSEcCtD
Omeprazole—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00662	CcSEcCtD
Omeprazole—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00624	CcSEcCtD
Omeprazole—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00619	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00617	CcSEcCtD
Omeprazole—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00607	CcSEcCtD
Omeprazole—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00605	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00605	CcSEcCtD
Omeprazole—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00596	CcSEcCtD
Omeprazole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00592	CcSEcCtD
Omeprazole—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00592	CcSEcCtD
Omeprazole—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00592	CcSEcCtD
Omeprazole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00581	CcSEcCtD
Omeprazole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00577	CcSEcCtD
Omeprazole—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00563	CcSEcCtD
Omeprazole—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00554	CcSEcCtD
Omeprazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00554	CcSEcCtD
Omeprazole—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00547	CcSEcCtD
Omeprazole—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00546	CcSEcCtD
Omeprazole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00541	CcSEcCtD
Omeprazole—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00539	CcSEcCtD
Omeprazole—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00536	CcSEcCtD
Omeprazole—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00528	CcSEcCtD
Omeprazole—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00528	CcSEcCtD
Omeprazole—Depression—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00527	CcSEcCtD
Omeprazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00515	CcSEcCtD
Omeprazole—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00515	CcSEcCtD
Omeprazole—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00513	CcSEcCtD
Omeprazole—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.001	0.00504	CcSEcCtD
Omeprazole—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000993	0.005	CcSEcCtD
Omeprazole—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000991	0.00498	CcSEcCtD
Omeprazole—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00496	CcSEcCtD
Omeprazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00493	CcSEcCtD
Omeprazole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00483	CcSEcCtD
Omeprazole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00475	CcSEcCtD
Omeprazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00474	CcSEcCtD
Omeprazole—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00472	CcSEcCtD
Omeprazole—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00472	CcSEcCtD
Omeprazole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000936	0.00471	CcSEcCtD
Omeprazole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00468	CcSEcCtD
Omeprazole—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00467	CcSEcCtD
Omeprazole—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00466	CcSEcCtD
Omeprazole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000924	0.00465	CcSEcCtD
Omeprazole—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00448	CcSEcCtD
Omeprazole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00443	CcSEcCtD
Omeprazole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00428	CcSEcCtD
Omeprazole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00427	CcSEcCtD
Omeprazole—Chills—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00426	CcSEcCtD
Omeprazole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00419	CcSEcCtD
Omeprazole—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000826	0.00415	CcSEcCtD
Omeprazole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00413	CcSEcCtD
Omeprazole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00407	CcSEcCtD
Omeprazole—Tension—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00405	CcSEcCtD
Omeprazole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00404	CcSEcCtD
Omeprazole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000797	0.00401	CcSEcCtD
Omeprazole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00399	CcSEcCtD
Omeprazole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00397	CcSEcCtD
Omeprazole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000769	0.00387	CcSEcCtD
Omeprazole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000761	0.00383	CcSEcCtD
Omeprazole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00382	CcSEcCtD
Omeprazole—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00379	CcSEcCtD
Omeprazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00075	0.00377	CcSEcCtD
Omeprazole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00372	CcSEcCtD
Omeprazole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00371	CcSEcCtD
Omeprazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000735	0.0037	CcSEcCtD
Omeprazole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00365	CcSEcCtD
Omeprazole—Cough—Riluzole—amyotrophic lateral sclerosis	0.000716	0.0036	CcSEcCtD
Omeprazole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00356	CcSEcCtD
Omeprazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00351	CcSEcCtD
Omeprazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00351	CcSEcCtD
Omeprazole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00351	CcSEcCtD
Omeprazole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000696	0.0035	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00349	CcSEcCtD
Omeprazole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00347	CcSEcCtD
Omeprazole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00344	CcSEcCtD
Omeprazole—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000675	0.0034	CcSEcCtD
Omeprazole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00067	0.00337	CcSEcCtD
Omeprazole—Infection—Riluzole—amyotrophic lateral sclerosis	0.000665	0.00335	CcSEcCtD
Omeprazole—Shock—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00331	CcSEcCtD
Omeprazole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000657	0.0033	CcSEcCtD
Omeprazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000656	0.0033	CcSEcCtD
Omeprazole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000654	0.00329	CcSEcCtD
Omeprazole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00327	CcSEcCtD
Omeprazole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00326	CcSEcCtD
Omeprazole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000638	0.00321	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00061	0.00307	CcSEcCtD
Omeprazole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00305	CcSEcCtD
Omeprazole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00303	CcSEcCtD
Omeprazole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000597	0.003	CcSEcCtD
Omeprazole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000595	0.003	CcSEcCtD
Omeprazole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00059	0.00297	CcSEcCtD
Omeprazole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00293	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00291	CcSEcCtD
Omeprazole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000577	0.0029	CcSEcCtD
Omeprazole—Pain—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00288	CcSEcCtD
Omeprazole—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00288	CcSEcCtD
Omeprazole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000552	0.00278	CcSEcCtD
Omeprazole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00276	CcSEcCtD
Omeprazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00268	CcSEcCtD
Omeprazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00266	CcSEcCtD
Omeprazole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00266	CcSEcCtD
Omeprazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00248	CcSEcCtD
Omeprazole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000481	0.00242	CcSEcCtD
Omeprazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000474	0.00238	CcSEcCtD
Omeprazole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00231	CcSEcCtD
Omeprazole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00223	CcSEcCtD
Omeprazole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000426	0.00214	CcSEcCtD
Omeprazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00212	CcSEcCtD
Omeprazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00212	CcSEcCtD
Omeprazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00211	CcSEcCtD
Omeprazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000398	0.002	CcSEcCtD
Omeprazole—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	4.75e-05	0.0021	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.7e-05	0.00207	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.7e-05	0.00207	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.66e-05	0.00206	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.65e-05	0.00205	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.62e-05	0.00204	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.57e-05	0.00202	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.51e-05	0.00199	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.51e-05	0.00199	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	4.42e-05	0.00195	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.38e-05	0.00193	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.34e-05	0.00191	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.31e-05	0.0019	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	4.3e-05	0.0019	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.28e-05	0.00189	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.25e-05	0.00188	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.25e-05	0.00187	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.2e-05	0.00185	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.18e-05	0.00184	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.13e-05	0.00182	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.12e-05	0.00182	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.1e-05	0.00181	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.1e-05	0.00181	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.08e-05	0.0018	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.98e-05	0.00176	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.97e-05	0.00175	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.95e-05	0.00174	CbGpPWpGaD
Omeprazole—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	3.95e-05	0.00174	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.93e-05	0.00174	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.87e-05	0.00171	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.83e-05	0.00169	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.76e-05	0.00166	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.75e-05	0.00165	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.72e-05	0.00164	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.64e-05	0.0016	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.64e-05	0.0016	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.63e-05	0.0016	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.62e-05	0.0016	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.6e-05	0.00159	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.59e-05	0.00158	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.57e-05	0.00158	CbGpPWpGaD
Omeprazole—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00158	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.49e-05	0.00154	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.44e-05	0.00152	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.41e-05	0.00151	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.38e-05	0.00149	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	3.35e-05	0.00148	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.32e-05	0.00147	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.28e-05	0.00145	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.28e-05	0.00145	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	3.26e-05	0.00144	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.26e-05	0.00144	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.25e-05	0.00144	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.24e-05	0.00143	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.21e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.18e-05	0.0014	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.13e-05	0.00138	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	3.09e-05	0.00136	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.04e-05	0.00134	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	3.01e-05	0.00133	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.96e-05	0.00131	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.96e-05	0.00131	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.93e-05	0.00129	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.92e-05	0.00129	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.79e-05	0.00123	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.78e-05	0.00122	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.78e-05	0.00122	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.74e-05	0.00121	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.73e-05	0.0012	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.71e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.7e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.69e-05	0.00119	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.68e-05	0.00118	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.67e-05	0.00118	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.59e-05	0.00114	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.00114	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.56e-05	0.00113	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.55e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.54e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.54e-05	0.00112	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.54e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.54e-05	0.00112	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.47e-05	0.00109	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.47e-05	0.00109	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	0.00108	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.37e-05	0.00105	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.36e-05	0.00104	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.33e-05	0.00103	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.31e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.31e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.28e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.28e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.27e-05	0.001	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.27e-05	0.001	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.25e-05	0.000994	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.25e-05	0.000991	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.22e-05	0.000979	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.22e-05	0.000978	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.22e-05	0.000978	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.2e-05	0.000971	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.18e-05	0.000961	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.16e-05	0.000955	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.12e-05	0.000934	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.09e-05	0.000922	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.09e-05	0.000922	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.08e-05	0.000917	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.08e-05	0.000916	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.07e-05	0.000915	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.07e-05	0.000914	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.07e-05	0.000914	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.03e-05	0.000898	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.03e-05	0.000895	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.01e-05	0.000885	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.97e-05	0.000867	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.97e-05	0.000867	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.93e-05	0.000852	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.93e-05	0.000852	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.91e-05	0.000843	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.89e-05	0.000836	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.89e-05	0.000832	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.87e-05	0.000826	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.84e-05	0.000812	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.83e-05	0.000809	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.82e-05	0.000801	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.000786	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.78e-05	0.000784	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.77e-05	0.000782	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.77e-05	0.000781	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.77e-05	0.000781	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.76e-05	0.000777	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.76e-05	0.000776	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.75e-05	0.000773	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.71e-05	0.000753	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.7e-05	0.000751	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.67e-05	0.000737	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.66e-05	0.000733	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.66e-05	0.00073	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.65e-05	0.000728	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.64e-05	0.000725	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.62e-05	0.000714	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.6e-05	0.000707	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000696	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.54e-05	0.000681	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000671	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.51e-05	0.000666	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.5e-05	0.000664	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.5e-05	0.000661	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000639	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.41e-05	0.000624	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000619	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.39e-05	0.000615	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.38e-05	0.000608	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.37e-05	0.000603	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.37e-05	0.000603	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.36e-05	0.000602	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.33e-05	0.000586	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.29e-05	0.000568	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.28e-05	0.000565	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.28e-05	0.000564	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000564	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000553	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.25e-05	0.000551	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.24e-05	0.000549	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000538	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.21e-05	0.000536	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000526	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000517	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.17e-05	0.000516	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.16e-05	0.000512	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	0.000509	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.15e-05	0.000507	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.14e-05	0.000505	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.13e-05	0.000501	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.12e-05	0.000495	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.09e-05	0.000482	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.09e-05	0.000479	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	0.000466	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.06e-05	0.000466	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000464	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.05e-05	0.000462	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.000461	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000455	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.01e-05	0.000444	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	1e-05	0.000443	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.87e-06	0.000436	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	9.7e-06	0.000428	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.64e-06	0.000425	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.54e-06	0.000421	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.43e-06	0.000416	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.24e-06	0.000408	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.21e-06	0.000406	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.15e-06	0.000404	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.95e-06	0.000395	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.67e-06	0.000383	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.61e-06	0.00038	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.6e-06	0.000379	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.41e-06	0.000371	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.2e-06	0.000362	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.17e-06	0.00036	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.15e-06	0.00036	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.85e-06	0.000346	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	7.61e-06	0.000336	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.48e-06	0.00033	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	7.35e-06	0.000324	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.21e-06	0.000318	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.07e-06	0.000312	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	6.92e-06	0.000305	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.91e-06	0.000305	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.88e-06	0.000303	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.71e-06	0.000296	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.61e-06	0.000291	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.19e-06	0.000273	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.9e-06	0.00026	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.69e-06	0.000251	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.68e-06	0.000251	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.67e-06	0.00025	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.38e-06	0.000237	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.22e-06	0.00023	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.21e-06	0.00023	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.07e-06	0.000224	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.95e-06	0.000218	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.74e-06	0.000209	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.68e-06	0.000207	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.66e-06	0.000206	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.66e-06	0.000206	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.62e-06	0.000204	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.59e-06	0.000203	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.55e-06	0.000201	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.29e-06	0.000189	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.28e-06	0.000189	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.25e-06	0.000187	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.95e-06	0.000174	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.83e-06	0.000169	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.74e-06	0.000165	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.63e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.53e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.49e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.21e-06	0.000142	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.05e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.99e-06	0.000132	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.94e-06	0.00013	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.8e-06	0.000124	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.63e-06	0.000116	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.56e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.42e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.39e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.3e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.05e-06	9.03e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-06	6.97e-05	CbGpPWpGaD
